Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GUM Dental mouthwash is an over-the-counter oral rinse formulated for the prevention and management of gum problems such as gingivitis and bad breath. It is produced by Sunstar under the "GUM" brand. The product line includes several formulations, most notably: - **GUM PAROEX 0.12% Intensive Action Mouthwash**, which contains chlorhexidine digluconate (an antiseptic), cetylpyridinium chloride (CPC), and other excipients[1]. - **GUM Dental Rinse Alcohol Free**, which features a double antibacterial system with cetylpyridinium chloride (CPC) and benzalkonium chloride (BKC), as well as licorice root extract for gum strengthening[2]. The primary mechanism of action involves broad-spectrum antibacterial activity that targets oral bacteria responsible for plaque formation, gingivitis, and halitosis. Chlorhexidine digluconate disrupts bacterial cell membranes leading to cell death, while CPC and BKC are quaternary ammonium compounds that also act on bacterial membranes. These rinses are alcohol-free in some variants, suitable for daily use after brushing or between meals to reduce bacteria in hard-to-reach areas. They are recommended especially for individuals with gum problems or persistent bad breath.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GUM Dental mouthwash.